Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 20 of 23
A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
NCT01188096
Distal Locking Using an Electromagnetic Field Guided Computer Based Real Time System for Orthopaedic Trauma Patients
NCT01183078
Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
NCT01197664
Evaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery
NCT01167907
Lactation Education Study in Mothers of Very Low Birth Weight Infants
NCT01167517
Combination Gel and Vascular ND in Mild to Moderate Rosacea
NCT01631656
Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
NCT01845116
Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System
NCT01059357
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors
NCT01113554
Idiopathic Recurrent Acute Pancreatitis (IRAP)
NCT01133535
Study of Biotene OralBalance Gel for Oral Care in Critically-Ill Mechanically Ventilated Neonates
NCT01314742
Building Social Networks to Enhance Postpartum Weight Loss and Appropriate Infant Feeding Practices
NCT01081340
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT01126346
Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest
NCT01119807
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
NCT01103375
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
NCT01053494
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
NCT01051479
Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic Malignancies
NCT01034475
Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
NCT01009983
Physical Activity, Weight and Fitness Outcomes in Children in After-Care
NCT01063413
Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size
NCT01028612
Patient Registry: Partial Breast Irradiation
NCT01127971
Translating Dietary Trials Into the Community
NCT00964483
Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy
NCT00994279
Vitamin D Supplementation and Physical Function in Older Adults
NCT01179503
Randomized Investigation of Chest Pain Diagnostic Strategies
NCT01035047
Assessment of Acute Disease to Reduce Imaging Costs
NCT01059500
Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
NCT01026467
Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab
NCT01435265
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
NCT01051401
Do Motion Metrics Lead to Improved Skill Acquisition on Simulators?
NCT01052168
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
NCT01553539
Prevalence of Sleep Disturbances in Psoriasis
NCT00895375
Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia
NCT02198131
Investigating Fitness Interventions in the Elderly (INFINITE)
NCT01048736
Dietary Patterns and Cardiovascular (CVD) Risk in Spinal Cord Injury (SCI) Factors In Individuals With Chronic Spinal Cord Injury
NCT01025609
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
NCT01176786
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
NCT01093469
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
NCT01003249
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
NCT00779324
A Comparison of Different Ventilation Strategies in Children Using the Proseal™ Laryngeal Mask Airway
NCT00966433
Combined Spinal/Epidural (CSE) Saline Duration/Spread
NCT01062893
Donor Lymphocyte Infusion After Alternative Donor Transplantation
NCT01027702
T-cell Depleted Alternative Donor Transplantation
NCT00968864
Effects of Aliskiren on Patient With Heart Failure and a Normal Ejection Fraction
NCT00982033
Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm
NCT01124773
Dual Site Left Ventricular (LV) Pacing
NCT00944125
Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
NCT01580410
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
NCT01145066
Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer
NCT00856453
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.